A drug fashioned from a mouse antibody has halted the progression of diabetes in children and young adults who are newly diagnosed with the disease. By blunting the immune system’s attack on insulin-making cells in these patients, the treatment may offer a way to forestall the disease.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.